ODEFSEY is 3 medicines in 1 pill. It is a combination of emtricitabine, rilpivirine, and tenofovir alafenamide. View the Patient Information with important warnings. Ask your healthcare …

2025年3月12日 · Odefsey is a prescription medicine that is used to treat Human Immunodeficiency Virus-1 (HIV-1) in people who have never taken HIV medicines before. This medicine is not a cure for HIV or AIDS. Odefsey is for use …

2024年8月4日 · Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) is commonly used to treat human immunodeficiency virus (HIV). Odefsey may also be used for other conditions as determined by your...

2023年10月11日 · Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide) is a combination of two HIV nucleoside analog reverse transcriptase inhibitors (NRTIs) and a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those ...

Odefsey is a combination pill containing three drugs: Rilpivirine is an antiretroviral drug of a type called a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ‘non-nuke’

ODEFSEY is a prescription medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection in adults and children who weigh at least 55 pounds (25 kg): • who have not received HIV-1 medicines in the past and who have an amount of HIV-1 in their blood (this

2025年3月9日 · ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 25 kg: as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL or

ODEFSEY is a three-drug fixed dose combination product containing 200 mg of emtricitabine (FTC), 25 mg of rilpivirine (RPV), and 25 mg of tenofovir alafenamide (TAF). The recommended dosage of ODEFSEY is one tablet taken orally once daily with a meal in adults and pediatric patients with body weight at least 25 kg and creatinine clearance

2025年2月24日 · ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 25 kg: as initial therapy in those with no antiretroviral ...

2018年1月10日 · ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL; or to replace a stable antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA ...